TTM
$72.25B
YoY change
+44.7%
5Y CAGR
+21.6%
Peak year (2025)
$65.18B
Cumulative revenue
$703.42B
Revenue history chart for Eli Lilly (LLY) from 1985 to 2025
Latest: $65.18B
Revenue growth chart for Eli Lilly (LLY) from 1985 to 2025
Latest: +44.7%
Revenue history table for Eli Lilly (LLY) from 1985 to 2025
| 2025 | $65.18B | +44.7% | +$20.14B | ||
| 2024 | $45.04B | +32.0% | +$10.92B | ||
| 2023 | $34.12B | +19.6% | +$5.58B | ||
| 2022 | $28.54B | +0.8% | +$223.00M | ||
| 2021 | $28.32B | +15.4% | +$3.78B | ||
| 2020 | $24.54B | +9.9% | +$2.22B | ||
| 2019 | $22.32B | +3.8% | +$826.20M | ||
| 2018 | $21.49B | +7.6% | +$1.52B | ||
| 2017 | $19.97B | -5.9% | −$1.25B | ||
| 2016 | $21.22B | +6.3% | +$1.26B | ||
| 2015 | $19.96B | +1.7% | +$343.10M | ||
| 2014 | $19.62B | -15.1% | −$3.50B | ||
| 2013 | $23.11B | +2.3% | +$509.70M | ||
| 2012 | $22.60B | -6.9% | −$1.68B | ||
| 2011 | $24.29B | +5.2% | +$1.21B | ||
| 2010 | $23.08B | +5.7% | +$1.24B | ||
| 2009 | $21.84B | +7.2% | +$1.46B | ||
| 2008 | $20.37B | +9.3% | +$1.74B | ||
| 2007 | $18.63B | +18.8% | +$2.94B | ||
| 2006 | $15.69B | +7.1% | +$1.05B | ||
| 2005 | $14.65B | +5.7% | +$787.40M | ||
| 2004 | $13.86B | +10.1% | +$1.28B | ||
| 2003 | $12.58B | +13.6% | +$1.50B | ||
| 2002 | $11.08B | -4.0% | −$465.00M | ||
| 2001 | $11.54B | +6.3% | +$680.30M | ||
| 2000 | $10.86B | +8.6% | +$859.30M | ||
| 1999 | $10.00B | +8.3% | +$766.10M | ||
| 1998 | $9.24B | +15.6% | +$1.25B | ||
| 1997 | $7.99B | +14.1% | +$989.40M | ||
| 1996 | $7.00B | +3.5% | +$234.50M | ||
| 1995 | $6.76B | +18.4% | +$1.05B | ||
| 1994 | $5.71B | -11.5% | −$740.80M | ||
| 1993 | $6.45B | +4.6% | +$285.10M | ||
| 1992 | $6.17B | +7.7% | +$441.60M | ||
| 1991 | $5.73B | +10.3% | +$534.10M | ||
| 1990 | $5.19B | +24.3% | +$1.02B | ||
| 1989 | $4.18B | +2.6% | +$105.90M | ||
| 1988 | $4.07B | +11.7% | +$425.90M | ||
| 1987 | $3.64B | -2.1% | −$76.60M | ||
| 1986 | $3.72B | +13.8% | +$449.80M | ||
| 1985 | $3.27B | — | — |
- 2025$65.18B+44.7%
- 2024$45.04B+32.0%
- 2023$34.12B+19.6%
- 2022$28.54B+0.8%
- 2021$28.32B+15.4%
- 2020$24.54B+9.9%
- 2019$22.32B+3.8%
- 2018$21.49B+7.6%
- 2017$19.97B-5.9%
- 2016$21.22B+6.3%
- 2015$19.96B+1.7%
- 2014$19.62B-15.1%
- 2013$23.11B+2.3%
- 2012$22.60B-6.9%
- 2011$24.29B+5.2%
- 2010$23.08B+5.7%
- 2009$21.84B+7.2%
- 2008$20.37B+9.3%
- 2007$18.63B+18.8%
- 2006$15.69B+7.1%
- 2005$14.65B+5.7%
- 2004$13.86B+10.1%
- 2003$12.58B+13.6%
- 2002$11.08B-4.0%
- 2001$11.54B+6.3%
- 2000$10.86B+8.6%
- 1999$10.00B+8.3%
- 1998$9.24B+15.6%
- 1997$7.99B+14.1%
- 1996$7.00B+3.5%
- 1995$6.76B+18.4%
- 1994$5.71B-11.5%
- 1993$6.45B+4.6%
- 1992$6.17B+7.7%
- 1991$5.73B+10.3%
- 1990$5.19B+24.3%
- 1989$4.18B+2.6%
- 1988$4.07B+11.7%
- 1987$3.64B-2.1%
- 1986$3.72B+13.8%
- 1985$3.27B—
Revenue values are taken from Eli Lilly's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's current revenue (TTM) is $72.25B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Eli Lilly (LLY) reported revenue of $65.18B – surged 44.7% year-over-year.
Eli Lilly revenue compound annual growth for the 2020–2025 (5 years) window is +21.6%, sustaining 8 straight years of year-over-year growth.
The record annual revenue stands at $65.18B, reached in 2025; the historical low of $3.27B was recorded in 1985.
Eli Lilly Revenue by Year
Eli Lilly Revenue 2025: $65.18B
2025's revenue for Eli Lilly came in at $65.18B, surged 44.7% from 2024. This figure represents the highest annual value in the available history.
Eli Lilly Revenue 2024: $45.04B
Eli Lilly posted revenue of $45.04B in 2024, surged 32.0% from 2023.
Eli Lilly Revenue 2023: $34.12B
In 2023, Eli Lilly reported revenue of $34.12B, grew 19.6% from 2022.
Eli Lilly Revenue 2022: $28.54B
Eli Lilly revenue in 2022 was $28.54B, edged up 0.8% from 2021.
Eli Lilly Revenue 2021: $28.32B
Eli Lilly revenue in 2021 was $28.32B.
See more financial history for Eli Lilly (LLY).
Sector peers by Revenue
Healthcare peers of Eli Lilly (LLY), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $44.56B | |
| $36.74B |
- $447.57B
- $94.19B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation